Compugen Posts Declining Revenue, Widened Loss in Q4

genomeweb
360dx

Compugen Posts Declining Revenue, Widened Loss in Q4

Feb 13, 2002

NEW YORK, Feb. 13 - Compugen on Wednesday reported that revenue shrank in the fourth quarter as a moderate increase in R&D spending conspired to widen net losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Neanderthal DNA Not Continuously Removed From Modern Human Genomes Over Last 55K Years
Immunological Data Sharing Consortium Wins €8.4M Award From EU, Canada
Researchers Generate Catalog of Kinase Response to DNA-Damaging Agents
Hundreds of Genetic Variants Implicated in Tobacco, Alcohol Use
Mutation in Inflammation-Related Gene Protects Against Nasal Polyps, Chronic Rhinosinusitis
NimaGen Licenses PCR Tech From Salisbury NHS Foundation Trust

The Scan

Refined Risk Prediction

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

Shutdown and the FDA

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

This Week in PNAS

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

Influences from Here and There

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.

Main menu